Literature DB >> 26476540

T cells in tumor microenvironment.

Yağmur Kiraz1,2, Yusuf Baran1,2, Ayten Nalbant3.   

Abstract

Tumors progress in a specific area, which supports its development, spreading or shrinking in time with the presence of different factors that effect the fate of the cancer cells. This specialized site is called "tumor microenvironment" and has a composition of heterogenous materials. The immune cells are also residents of this stromal, cancerous, and inflammatory environment, and their types, densities, or functional differences are one of the key factors that mediate the fate of a tumor. T cells as a vital part of the immune system also are a component of tumor microenvironment, and their roles have been elucidated in many studies. In this review, we focused on the immune system components by focusing on T cells and detailed T helper cell subsets in tumor microenvironment and how their behaviors affect either the tumor or the patient's outcome.

Entities:  

Keywords:  Cancer immunology; T cells; T helper cells; Th17 cells; Tumor microenvironment

Mesh:

Year:  2015        PMID: 26476540     DOI: 10.1007/s13277-015-4241-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  45 in total

Review 1.  Effector and regulatory events during natural killer-dendritic cell interactions.

Authors:  Lorenzo Moretta; Guido Ferlazzo; Cristina Bottino; Massimo Vitale; Daniela Pende; Maria Cristina Mingari; Alessandro Moretta
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

2.  Effector memory T cells, early metastasis, and survival in colorectal cancer.

Authors:  Franck Pagès; Anne Berger; Matthieu Camus; Fatima Sanchez-Cabo; Anne Costes; Robert Molidor; Bernhard Mlecnik; Amos Kirilovsky; Malin Nilsson; Diane Damotte; Tchao Meatchi; Patrick Bruneval; Paul-Henri Cugnenc; Zlatko Trajanoski; Wolf-Herman Fridman; Jérôme Galon
Journal:  N Engl J Med       Date:  2005-12-22       Impact factor: 91.245

Review 3.  Acquisition of lymphokine-producing phenotype by CD4+ T cells.

Authors:  R A Seder; W E Paul
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

4.  Model predicting survival in stage I melanoma based on tumor progression.

Authors:  W H Clark; D E Elder; D Guerry; L E Braitman; B J Trock; D Schultz; M Synnestvedt; A C Halpern
Journal:  J Natl Cancer Inst       Date:  1989-12-20       Impact factor: 13.506

5.  CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer.

Authors:  Y Naito; K Saito; K Shiiba; A Ohuchi; K Saigenji; H Nagura; H Ohtani
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

Review 6.  Fibroblast independency in tumors: implications in cancer therapy.

Authors:  Erasmia Tsellou; Hippokratis Kiaris
Journal:  Future Oncol       Date:  2008-06       Impact factor: 3.404

7.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer.

Authors:  Lin Zhang; Jose R Conejo-Garcia; Dionyssios Katsaros; Phyllis A Gimotty; Marco Massobrio; Giorgia Regnani; Antonis Makrigiannakis; Heidi Gray; Katia Schlienger; Michael N Liebman; Stephen C Rubin; George Coukos
Journal:  N Engl J Med       Date:  2003-01-16       Impact factor: 91.245

8.  Dendritic cell editing by activated natural killer cells results in a more protective cancer-specific immune response.

Authors:  Barbara Morandi; Lorenzo Mortara; Laura Chiossone; Roberto S Accolla; Maria Cristina Mingari; Lorenzo Moretta; Alessandro Moretta; Guido Ferlazzo
Journal:  PLoS One       Date:  2012-06-19       Impact factor: 3.240

Review 9.  Th17 cells in cancer: the ultimate identity crisis.

Authors:  Stefanie R Bailey; Michelle H Nelson; Richard A Himes; Zihai Li; Shikhar Mehrotra; Chrystal M Paulos
Journal:  Front Immunol       Date:  2014-06-17       Impact factor: 7.561

10.  Trial watch: Prognostic and predictive value of the immune infiltrate in cancer.

Authors:  Laura Senovilla; Erika Vacchelli; Jerome Galon; Sandy Adjemian; Alexander Eggermont; Wolf Hervé Fridman; Catherine Sautès-Fridman; Yuting Ma; Eric Tartour; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2012-11-01       Impact factor: 8.110

View more
  2 in total

1.  In vitro and in vivo anti-tumor effects of selected platinum(IV) and dinuclear platinum(II) complexes against lung cancer cells.

Authors:  Milos Arsenijevic; Marija Milovanovic; Snezana Jovanovic; Natalija Arsenijevic; Bojana Simovic Markovic; Marina Gazdic; Vladislav Volarevic
Journal:  J Biol Inorg Chem       Date:  2017-04-18       Impact factor: 3.358

2.  Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma.

Authors:  Si Li; Fangying Xu; Jing Zhang; Lili Wang; Yang Zheng; Xuesong Wu; Jing Wang; Qiong Huang; Maode Lai
Journal:  Oncoimmunology       Date:  2017-10-11       Impact factor: 8.110

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.